Literature DB >> 3932269

Interactions between bronchoalveolar lymphocytes and macrophages in heart-lung transplant recipients.

J J Fung, A Zeevi, C Kaufman, I L Paradis, J H Dauber, R L Hardesty, B Griffith, R J Duquesnoy.   

Abstract

Bronchoalveolar lavages (BAL) were obtained from heart-lung transplant patients. Following transplantation, the number of lymphocytes and macrophages are considerably increased. BAL lymphocytes frequently exhibit donor specific secondary allogeneic proliferation measured in primed lymphocyte testing (PLT) assays. We report our findings regarding a persistence of donor derived macrophages and lymphocytes in BAL during the posttransplant period. The presence of donor specific macrophages causes a proliferative response of alloreactive BAL lymphocytes from the recipient. This "Bronchoalveolar Macrophage Lymphocyte Reaction," or "BMLR," may represent a unique aspect of in vivo interactions associated with lung allograft responses. Comparative studies showed considerably lower PLT responsiveness of peripheral blood lymphocytes than that of BAL lymphocytes. These studies suggest that functional assays on BAL cells may be useful in monitoring lung transplant rejection and other immunological phenomena that affect pulmonary function of heart-lung transplant patients.

Entities:  

Mesh:

Year:  1985        PMID: 3932269     DOI: 10.1016/0198-8859(85)90236-8

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  10 in total

Review 1.  Cell migration, chimerism, and graft acceptance.

Authors:  T E Starzl; A J Demetris; N Murase; S Ildstad; C Ricordi; M Trucco
Journal:  Lancet       Date:  1992-06-27       Impact factor: 79.321

2.  CXCR6 identifies a putative population of retained human lung T cells characterised by co-expression of activation markers.

Authors:  Angela J Morgan; Cristina Guillen; Fiona A Symon; Surinder S Birring; James J Campbell; Andrew J Wardlaw
Journal:  Immunobiology       Date:  2008-03-07       Impact factor: 3.144

3.  Dynamics of allospecific T lymphocyte infiltration in vascularized human allografts.

Authors:  J J Fung; A Zeevi; B Markus; T R Zerbe; R J Duquesnoy
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

Review 4.  Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance.

Authors:  T E Starzl; A J Demetris; M Trucco; N Murase; C Ricordi; S Ildstad; H Ramos; S Todo; A Tzakis; J J Fung
Journal:  Hepatology       Date:  1993-06       Impact factor: 17.425

5.  Antibody-functionalized peptidic membranes for neutralization of allogeneic skin antigen-presenting cells.

Authors:  Yi Wen; Wen Liu; Christina Bagia; Shaojuan Zhang; Mingfeng Bai; Jelena M Janjic; Nick Giannoukakis; Ellen S Gawalt; Wilson S Meng
Journal:  Acta Biomater       Date:  2014-08-10       Impact factor: 8.947

6.  Replacement of donor lymphoid tissue in small-bowel transplants.

Authors:  Y Iwaki; T E Starzl; A Yagihashi; S Taniwaki; K Abu-Elmagd; A Tzakis; J Fung; S Todo
Journal:  Lancet       Date:  1991-04-06       Impact factor: 79.321

7.  Origin of lymph node-derived lymphocytes in human hepatic allografts.

Authors:  John J Fung; Adriane Zeevi; A Jake Demetris; Thomas E Starzl; Bernd Markus; Kangnian Chen; Marilyn Marrarri; Rene J Duquesnoy
Journal:  Clin Transpl       Date:  1989

8.  Cadaveric small bowel and small bowel-liver transplantation in humans.

Authors:  S Todo; A G Tzakis; K Abu-Elmagd; J Reyes; J J Fung; A Casavilla; K Nakamura; A Yagihashi; A Jain; N Murase
Journal:  Transplantation       Date:  1992-02       Impact factor: 4.939

9.  Depletion of bronchus-associated lymphoid tissue associated with lung allograft rejection.

Authors:  R H Hruban; W E Beschorner; W A Baumgartner; S C Achuff; T A Traill; K A Digennaro; B A Reitz; G M Hutchins
Journal:  Am J Pathol       Date:  1988-07       Impact factor: 4.307

10.  Macrophage depletion of CMV latently infected donor hearts ameliorates recipient accelerated chronic rejection.

Authors:  Nicole N Haese; Jennifer M Burg; Takeshi F Andoh; Iris K A Jones; Craig N Kreklywich; Patricia P Smith; Susan L Orloff; Daniel N Streblow
Journal:  Transpl Infect Dis       Date:  2020-12-07       Impact factor: 2.228

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.